Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Ensysce Biosciences (ENSC) Asset Utilization Ratio (2020 - 2025)

Ensysce Biosciences (ENSC) has disclosed Asset Utilization Ratio for 6 consecutive years, with 1.03 as the latest value for Q3 2025.

  • On a quarterly basis, Asset Utilization Ratio rose 41.24% to 1.03 in Q3 2025 year-over-year; TTM through Sep 2025 was 1.03, a 41.24% increase, with the full-year FY2024 number at 1.25, up 141.67% from a year prior.
  • Asset Utilization Ratio was 1.03 for Q3 2025 at Ensysce Biosciences, down from 1.46 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 1.46 in Q2 2025 to a low of 0.15 in Q1 2021.
  • A 5-year average of 0.56 and a median of 0.45 in 2024 define the central range for Asset Utilization Ratio.
  • Peak YoY movement for Asset Utilization Ratio: crashed 37.29% in 2024, then skyrocketed 298.33% in 2025.
  • Ensysce Biosciences' Asset Utilization Ratio stood at 0.27 in 2021, then soared by 31.75% to 0.36 in 2022, then surged by 111.41% to 0.75 in 2023, then decreased by 7.6% to 0.7 in 2024, then skyrocketed by 47.43% to 1.03 in 2025.
  • Per Business Quant, the three most recent readings for ENSC's Asset Utilization Ratio are 1.03 (Q3 2025), 1.46 (Q2 2025), and 1.22 (Q1 2025).